Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Citi
Johnson and Johnson
Chubb
Federal Trade Commission
US Army
Merck
Argus Health
Cerilliant

Generated: June 17, 2018

DrugPatentWatch Database Preview

Claims for Patent: 3,897,779

« Back to Dashboard

Summary for Patent: 3,897,779
Title: Triamcinolone acetonide inhalation therapy
Abstract:An aerosol container carrier and deceleration chamber for dispensing powdered triamcinolone acetonide with inhaled particles predominantly below 10 microns in size at a low velocity gives a comparatively high degree of topical effect in the lungs as compared with systemic effect from triamcinolone acetonide absorbed in the mouth or upper throat. The suspension of triamcinolone acetonide in dichlorodifluoromethane is preferably subjected to sonic waves at about -40.degree.C, resulting in a suspension having increased physical stability. A suspending agent such as anhydrous ethanol or sorbitan trioleate also increases stability.
Inventor(s): Hansen; Lloyd Frank (Campbell Hall, NY)
Assignee: American Cyanamid Company (Stamford, CT)
Application Number:05/374,177
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 3,897,779
Patent Claims: 1. A method of treating asthma which comprises

dispensing a measured dose through a metering valve into a deceleration chamber of

a suspension in a chlorofluoroalkane propellant of finely divided triamcinolone acetonide having 95% by weight within the particle size range of about 0.5 to 10 microns, the individual particles of which are substantially separated,

mixing with additional air, and inhaling, by inspirational air velocity only, into the lungs of the subject, holding the inspired air for a short time to permit a substantial portion of the particles of triamcinolone acetonide to be deposited along the lung surface, and exhaling.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Harvard Business School
Chubb
Mallinckrodt
Express Scripts
Cipla
Farmers Insurance
Teva
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.